Method for detecting a single nucleotide polymorphism in p21waf1/cip1 gene as an indicator of risk of esophageal cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 30, 2003
Grant Date -
Sep 26, 2002
app pub date -
Dec 28, 2000
filing date -
Dec 28, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to analysis of the alterations in p21.sup.waf1/cip1 gene and its expression in relation to p53 status in esophageal cancer, a method for screening of subjects having or at risk of having esophageal cancer by detection of the polymorphism in p21.sup.waf1/cip1 gene, and use thereof as a diagnostic marker.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully